|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: QUESTCOR PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
Next: CELL THERAPEUTICS INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FORM
10-Q FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 9,043
<SECURITIES> 4,744
<RECEIVABLES> 483
<ALLOWANCES> (200)
<INVENTORY> 262
<CURRENT-ASSETS> 242
<PP&E> 4,092
<DEPRECIATION> (1,532)
<TOTAL-ASSETS> 21,545
<CURRENT-LIABILITIES> 9,678
<BONDS> 782
0
5,081
<COMMON> 66,154
<OTHER-SE> (60,826)
<TOTAL-LIABILITY-AND-EQUITY> 21,545
<SALES> 1,023
<TOTAL-REVENUES> 1,241
<CGS> 1,046
<TOTAL-COSTS> 10,215
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (59)
<INCOME-PRETAX> (8,998)
<INCOME-TAX> 0
<INCOME-CONTINUING> (8,998)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,998)
<EPS-BASIC> (0.36)
<EPS-DILUTED> (0.36)
</TABLE>
|
|